Avenacy announces the launch of Metoclopramide Injection, USP in the U.S. market
Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, announced it has launched Metoclopramide Injection, USP in the United States as a therapeutic generic equivalent for Reglan® as approved by the U.S.